These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10454234)

  • 1. Myoclonic encephalopathy and diabetes mellitus in a boy.
    Lenti C; Bognetti E; Bonfanti R; Bonifacio E; Meschi F
    Dev Med Child Neurol; 1999 Jul; 41(7):489-90. PubMed ID: 10454234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic vesicle-associated glutamate decarboxylase: identification and relationship to insulin-dependent diabetes mellitus.
    Nathan B; Floor E; Kuo CY; Wu JY
    J Neurosci Res; 1995 Jan; 40(1):134-7. PubMed ID: 7714921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opercular myoclonic-anarthric status epilepticus due to glutamic acid decarboxylase antibody-associated encephalitis.
    Monnerat BZ; Velasco TR; Nakano FN; Júnior AV; Martins AP; Sakamoto AC
    Epileptic Disord; 2013 Sep; 15(3):342-6. PubMed ID: 23981587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late infantile neuroaxonal dystrophy. An unusual case with predominantly myoclonic-epileptic symptomatology.
    Barontini F; Papini M
    Riv Patol Nerv Ment; 1981; 101(4):171-84. PubMed ID: 6789439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoclonic encephalopathy (Kinsbourne syndrome)].
    Kaulfersch W; Urban C; Fritsch G; Maurer G
    Padiatr Padol; 1984; 19(3):279-85. PubMed ID: 6472868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterovirus-related type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan.
    Kawashima H; Ihara T; Ioi H; Oana S; Sato S; Kato N; Takami T; Kashiwagi Y; Takekuma K; Hoshika A; Mori T
    J Infect; 2004 Aug; 49(2):147-51. PubMed ID: 15236922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonic seizures in Krabbe disease: a unique presentation in late-onset type.
    Morse LE; Rosman NP
    Pediatr Neurol; 2006 Aug; 35(2):154-7. PubMed ID: 16876017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with GAD in diabetes.
    Ludvigsson J
    Diabetes Metab Res Rev; 2009 May; 25(4):307-15. PubMed ID: 19267332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute onset of type I diabetes mellitus after severe echovirus 9 infection: putative pathogenic pathways.
    Vreugdenhil GR; Schloot NC; Hoorens A; Rongen C; Pipeleers DG; Melchers WJ; Roep BO; Galama JM
    Clin Infect Dis; 2000 Oct; 31(4):1025-31. PubMed ID: 11049787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
    Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
    Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria of food and human intestine are the most possible sources of the gad-trigger of type 1 diabetes.
    Mulder SJ
    Med Hypotheses; 2005; 65(2):308-11. PubMed ID: 15922105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY; Huang P; Lou HL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.